- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hepatitus C
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Drugs for the treatment of hepatitis c stakeholder meeting outcomes december 2018 (various) – March 2019
Drugs for the Treatment of Hepatitis C Stakeholder Meeting Outcomes December 2018 (various)
Last updated
5 July 2019